New player in blood cancer development

New player in blood cancer development

Researchers have uncovered a protein that is key to the development of blood cancers caused by a common genetic error.

The discovery is a missing piece in the puzzle of understanding how high levels of a protein called MYC drive cancer development. Seventy per cent of human cancers have abnormally high levels of MYC, which forces cells into unusually rapid growth.

Researchers discovered that blood cancers driven by MYC could be prevented by lowering the levels of another protein, called MCL-1.The research was published in the journal Cell Reports.

Author said the developing cancer cells were dependent on MCL-1, a protein that keeps stressed cells alive by preventing programmed cell death (apoptosis). "No one had realized just how vulnerable cells undergoing cancerous changes are to a relatively minor reduction in the levels of MCL-1. We found that MCL-1 is critical for keeping developing cancer cells alive through the stressful events that cause the transformation of a healthy cell into a cancerous cell.”

"This result is particularly exciting because MCL-1 inhibitors are already in development as anti-cancer drugs," author said. "Our colleagues had previously discovered that reducing the activity of MCL-1 is a promising strategy to treat malignant MYC-driven cancers. We have now shown that the same approach might be able to prevent those cancers from forming in the first place."
 
http://www.wehi.edu.au/news/new-vulnerability-revealed-blood-cancer-development

Edited

Rating

Unrated
Rating: